Jerel A. Banks's Insider Trades & SAST Disclosures

Jerel A. Banks's most recent trade in Benitec Biopharma Inc was a trade of 2,310,000 Options (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Benitec Biopharma Inc
Jerel A. Banks Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 2,310,000 2,310,000 - - Options (right to buy)
Benitec Biopharma Inc
Jerel A. Banks Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 466,554 466,554 - - Options (right to buy)
Benitec Biopharma Inc
Jerel A. Banks Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 356,900 356,900 - - Options (right to buy)
Benitec Biopharma Inc
Jerel A. Banks Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2020 284,345 284,345 - - Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades